Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 1/g
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product introduction:
CAS: 936563-96-1
MF: C25H24N6O2
Loss on drying: ≤1.0%
Purity: ≥99.0%
Description: Purity 99% Ibrutinib powder cas 936563-96-1 is an inhibitor of Bruton tyrosine kinase (BTK) for the treatment of chronic lymphoblastic leukemia (CLL) and sleeve cell lymphoma (MCL).
Application:
1. Purity 99% Ibrutinib powder cas 936563-96-1 is used for Chronic graft-versus-host (cGVHD) disease after failure of one or more prior lines of systemic therapy.
2. Chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
3. Mantle cell lymphoma (MCL) who have received at least one prior therapy.
4. Marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.
5. Waldenstrom's macroglobulinemia.